Qiagen NV | QIA - 资产

金融业

USD

USD 6.3B

现金及等价物

USD 839.01M

USD 217.43M

USD 2B

USD 512.14M

USD 1.81B

股息收益率

USD 0.56

USD 121.88M

USD 249.69M

USD 6.18K

EPS每股收益

USD 0.46

股本和储备

USD 3.78B

USD 325.27M

债务利息支出

USD 10.14M

USD 20M

USD 1.65B

USD 7.07B

USD 107.83M

USD 418.54M

USD 121.88M

普通股股本

USD 216.56M

20.54

USD 109.17M

USD 419.22M

销售和管理费用

USD 153.88M

USD 301.89M

贸易债权人

USD 72.66M

应收帐款人

USD 402.61M

	资产	更改		日
Akebia Therapeutics	USD 362.52M		14.04M	2026-03
Alaunos Therapeutics	USD 1.88M		1.08M	2026-03
argenx SE	USD 8.68B		1.51B	2025-12
Avita Medical	AUD 56.39M		1.74M	2025-12
Dianthus Therapeutics	USD 1.25B		715.96M	2026-03
Ionis Pharmaceuticals	USD 3.45B		74M	2026-03
IQVIA Holdings	USD 29.68B		269M	2026-03
Moderna	USD 11.49B		850M	2026-03
Organon & Co	USD 13B		129M	2026-03
Qiagen NV	USD 6.3B		257.54M	2025-12
Revvity	USD 12B		171.82M	2026-03
Tectonic Therapeutic	USD 246.58M		14.46M	2026-03
Viatris	USD 36.83B		358.5M	2026-03
Xeris Pharmaceuticals	USD 392.01M		8.49M	2026-03